Startseite>>Signaling Pathways>> Tyrosine Kinase>> Insulin Receptor>>AGL-2263

AGL-2263

Katalog-Nr.GC31371

AGL-2263 ist ein Insulinrezeptor- und insulinÄhnlicher Wachstumsfaktor (IGF)-Rezeptor-Inhibitor.

Products are for research use only. Not for human use. We do not sell to patients.

AGL-2263 Chemische Struktur

Cas No.: 638213-98-6

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
143,00 $
Auf Lager
1mg
69,00 $
Auf Lager
5mg
202,00 $
Auf Lager
10mg
321,00 $
Auf Lager
25mg
644,00 $
Auf Lager
50mg
1.103,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

AGL-2263 is an insulin receptor (IR) blocker.

AGL-2263 is an insulin receptor (IR) blocker[1].

[1]. Li Y, et al. GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptake. Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):E5697-705.

Bewertungen

Review for AGL-2263

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AGL-2263

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.